How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes

Diabetes Care

Volumn 22, Issue SUPPL. 2, 1999, Pages

  Bolli, Geremia B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO;

BLOOD GLUCOSE MONITORING; BRAIN METABOLISM; CONFERENCE PAPER; DIABETES CONTROL; FOOD INTAKE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MODEL; PATIENT EDUCATION;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BRAIN; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOGLYCEMIA; INSULIN; PATIENT EDUCATION; PERCEPTION;

EID: 0032972587     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Reichard P, Nilsson BY, Rosenquist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Amiel S, Archibald H, Chusney G, Williams A, Gale E: Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci 81:189-194, 1991
4. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J: Effect of hyperketonemia and hyperlactacidemia on symptoms, cognitive dysfunction and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes 43:1311-1317, 1994
5. Maran A, Cranston I, Lomas J, Macdonald I, Amiel S: Protection by lactate of cerebral function during hypoglycaemia. Lancet 343:16-20, 1994
6. Fanelli C, Di Vincenzo A, Modarelli F, Lepore M, Ciofetta M, Epifano L, Pampanelli S, Brunetti P, Bolli GB: Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced neuroglycopenia in humans. Diabetologia 36:1191-1197, 1993
7. Foster DW, Rubenstein AH: Hypoglycemia. In Harrison's Principles of Internal Medicine. Wilson JD, Braunwald H, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK, Eds. New York, McGraw-Hill, 1991, p. 1759-1762
8. Young CW, Karam JH: Hypoglycemic disorders. In Basic and Clinical Endocrinology. Greenspan FS, Ed. East Norwalk, CT, Appleton & Lange, 1991, p. 651-654
9. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenzo A, Annibale B, Lepore M, Lalli C, Del Sindaco F, Brunetti P, Bolli GB: Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37:797-807, 1994
10. Pampanelli S, Fanelli C, Lalli C, Ciofetta M, Del Sindaco P, Lepore M, Modarelli F, Rambotti AM, Epifano L, Di Vincenzo A, Bartocci L, Annibale B, Brunetti P, Bolli GB: Long-term intensive insulin therapy: effects of HbAlc, risk for severe and mild hypoglycaemia, status of counterregulation and unawareness of hypoglycaemia. Diabetologia 39:677-686, 1996
11. Bolli GB: From physiology of glucose counterregulation to prevention of hypoglycaemia in type 1 diabetes mellitus. Diabetes Nutr Metab 3:333-349, 1990
12. Bolli GB, Dimitriadis GD, Pehling GB, Baker BA, Haymond MW, Cryer PE, Gerich JE: Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med 310:1706-1711, 1984
13. Yki-Jarvinen H, Helve E, Koivisto VA: Hyperglycemia decreases glucose uptake in type 1 diabetes. Diabetes 36:892-896, 1987
14. Fanelli C, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia (near-)normalizes magnitude and glycemic thresholds of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with IDDM of short duration. Diabetes 42:1683-1689, 1993
15. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of a rationale, intensive insulin therapy in IDDM. Diabetologia 37:1265-1276, 1994
16. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Porcellati F, Bottini P, Di Vincenzo A, Bottini P, Brunetti P, Bolli GB: Long-term intensive therapy of IDDM diabetic patients with clinically overt autonomic neuropathy: effects on awareness of, and counterregulation to hypoglycemia. Diabetes 46:1172-1181, 1997
17. Bolli GB: Hypoglycemia unawareness. Diabetes Metab 23 (Suppl. 3):29-35, 1997
18. Fanelli CG, Pampanelli S, Porcellati F, Bolli GB: Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. Diabetologia 41:720-723, 1998
19. Boyle P, Kempers S, O'Connor AM, Nagy RJ: Brain glucose uptake and hypoglycemia unawareness in patients with insulin-dependent diabetes mellitus. N Engl J Med 333:1726-1731, 1995
20. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R: Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 98:680-691, 1996
21. Pampanelli S, Lalli C, Del Sindaco P, Lepore M, Ciofetta M, Fanelli C, Brunetti P, Bolli GB: Effect of recent, antecedent hypoglycemia and responses of cortisol per sé, on responses to subsequent hypoglycemia in humans. Diabetologia 40 (Suppl. 1):A27, 1997
22. Schade S, Santiago JV, Skyler JS, Rizza RA (Eds): Intensive Insulin Therapy. Amsterdam, Excerpta Medica, 1983
23. Bolli GB, Perriello G, Fanelli C, De Feo: Nocturnal blood glucose control in type 1 diabetes mellitus. Diabetes Care 16 (Suppl. 3):71-89, 1993
24. Dimitriadis G, Gerich J: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1983
25. Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli GB: Effects of the short-acting insulin analog [LYS(B28),-PRO(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
26. Dimitriadis G, Gerich J: Effect of twice daily subcutaneous administration of a long-acting somatostatin analog on 24-hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus. Horm Metab Res 10:510-511, 1985
27. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J: Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42:1233-1237, 1993
28. Bolli GB: The pharmacokinetic basis of insulin therapy in diabetes mellitus. Diabetes Res Clin Pract 6:S3-S16, 1989
29. Fanelli C, Pampanelli S, Lepore M, Porcellati F, Bartocci L, Brunetti P, Bolli GB: Prevention of nocturnal hypoglycemia in intensive therapy of IDDM (Abstract). Diabetes 47 (Suppl. 1). A109, 1998
30. Binder C, Lauritzen T, Faber O, Pramming S: Insulin pharmacokinetics. Diabetes Care 7:188-199, 1984
31. Markussen J, Havelund S, Kurtzhals P: Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia 39:281-288, 1996
32. ∈-palmitoyl Lys(B29)] human insulins in subjects with IDDM. Diabetologia 41:116-120, 1998
33. Seipke G, Geisen K, Neubauer HP, Pittius C, Rosskamp R, Schwabe D: New insulin preparations with prolonged profiles: A21-modified argine insulins. Diabetologia 35 (Suppl. 1):A4, 1992
34. Heine RJ, Bilo HJG, Sikkenk AC, van der Veen EA: Mixing short and intermediate acting insulins in the syringe: effect on post-prandial blood glucose concentrations in type 1 diabetics. BMJ 290:204-205, 1985
35. Brunelle RL, Llewelyn J, Anderson VA, Gale EAM, Koivisto VA: Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21:1726-1731
36. Ahmed AME, Home PD: The effect of insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients Diabetes Care 21:32-37, 1998
37. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack TR: Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 46:440-443, 1997
38. Jansson P-A, Ebeling P, Smith U, Conget I, Coves MJ, Gomis R, Lalli C, Del Sindaco P, Bolli GB, Koivisto VA: Improved glycemic control can be better maintained with insulin lispro than with human regular insulin. Diab Nutr Metab 11:194-199, 1998
39. Del Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, Brunetti P, Bolli GB: Use of the short-acting insulin analogue lispro in intensive treatment of IDDM: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med 15:592-600, 1998
40. Anderson JH, Brunelle R, Koivisto VA, Pfuetzner A, Trautman M, Vignati L, Di Marchi R: Insulin analogue treatment reduces postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients. Diabetes 46:265-270, 1997
41. Jacobs MAJM, Keulen ETP, Kanc K, Casteleijn S, Scheffer P, Deville W, Heine RJ: Metabolic efficacy of preprandial administration of Lys(B28),Pro(B29) human insulin analog in IDDM patients. Diabetes Care 20:1279-1292, 1997
42. Bott S, Bott U, Berger M, Muehlhauser I: Intensified insulin therapy and the risk for severe hypoglycaemia Diabetologia 40:926-932, 1997
43. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA: Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283-287, 1994
44. Dagogo-Jack S, Rattarasam C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994